Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1994 Nov;57(Suppl):26–28. doi: 10.1136/jnnp.57.suppl.26

Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies.

A J Steck 1, L Kappos 1
PMCID: PMC1016719  PMID: 7964847

Full text

PDF
26

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D., Kuntzer T., Burger D., Chofflon M., Magistris M. R., Regli F., Steck A. J. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol. 1991 Jun;32(3):223–230. doi: 10.1016/0165-5728(91)90192-a. [DOI] [PubMed] [Google Scholar]
  2. Bollensen E., Steck A. J., Schachner M. Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy. Neurology. 1988 Aug;38(8):1266–1270. doi: 10.1212/wnl.38.8.1266. [DOI] [PubMed] [Google Scholar]
  3. Braun P. E., Frail D. E., Latov N. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem. 1982 Nov;39(5):1261–1265. doi: 10.1111/j.1471-4159.1982.tb12563.x. [DOI] [PubMed] [Google Scholar]
  4. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992 Jun;31(6):677–679. doi: 10.1002/ana.410310619. [DOI] [PubMed] [Google Scholar]
  5. Dyck P. J., Low P. A., Windebank A. J., Jaradeh S. S., Gosselin S., Bourque P., Smith B. E., Kratz K. M., Karnes J. L., Evans B. A. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med. 1991 Nov 21;325(21):1482–1486. doi: 10.1056/NEJM199111213252105. [DOI] [PubMed] [Google Scholar]
  6. Feldman E. L., Bromberg M. B., Albers J. W., Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol. 1991 Sep;30(3):397–401. doi: 10.1002/ana.410300312. [DOI] [PubMed] [Google Scholar]
  7. Feldman E. L., Bromberg M. B., Albers J. W., Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol. 1991 Sep;30(3):397–401. doi: 10.1002/ana.410300312. [DOI] [PubMed] [Google Scholar]
  8. Freddo L., Yu R. K., Latov N., Donofrio P. D., Hays A. P., Greenberg H. S., Albers J. W., Allessi A. G., Keren D. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology. 1986 Apr;36(4):454–458. doi: 10.1212/wnl.36.4.454. [DOI] [PubMed] [Google Scholar]
  9. Kaji R., Oka N., Tsuji T., Mezaki T., Nishio T., Akiguchi I., Kimura J. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol. 1993 Feb;33(2):152–158. doi: 10.1002/ana.410330204. [DOI] [PubMed] [Google Scholar]
  10. Kaji R., Shibasaki H., Kimura J. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology. 1992 Mar;42(3 Pt 1):506–509. doi: 10.1212/wnl.42.3.506. [DOI] [PubMed] [Google Scholar]
  11. Marcus D. M., Latov N., Hsi B. P., Gillard B. K. Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A. J Neuroimmunol. 1989 Dec;25(2-3):255–259. doi: 10.1016/0165-5728(89)90144-6. [DOI] [PubMed] [Google Scholar]
  12. Nobile-Orazio E., Meucci N., Barbieri S., Carpo M., Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology. 1993 Mar;43(3 Pt 1):537–544. doi: 10.1212/wnl.43.3_part_1.537. [DOI] [PubMed] [Google Scholar]
  13. Pestronk A., Adams R. N., Clawson L., Cornblath D., Kuncl R. W., Griffin D., Drachman D. B. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 1988 Sep;38(9):1457–1461. doi: 10.1212/wnl.38.9.1457. [DOI] [PubMed] [Google Scholar]
  14. Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve. 1991 Oct;14(10):927–936. doi: 10.1002/mus.880141002. [DOI] [PubMed] [Google Scholar]
  15. Sadiq S. A., Thomas F. P., Kilidireas K., Protopsaltis S., Hays A. P., Lee K. W., Romas S. N., Kumar N., van den Berg L., Santoro M. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 1990 Jul;40(7):1067–1072. doi: 10.1212/wnl.40.7.1067. [DOI] [PubMed] [Google Scholar]
  16. Steck A. J. Inflammatory neuropathy: pathogenesis and clinical features. Curr Opin Neurol Neurosurg. 1992 Oct;5(5):633–637. [PubMed] [Google Scholar]
  17. Steck A. J., Murray N., Dellagi K., Brouet J. C., Seligmann M. Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol. 1987 Dec;22(6):764–767. doi: 10.1002/ana.410220614. [DOI] [PubMed] [Google Scholar]
  18. Vital A., Vital C., Julien J., Baquey A., Steck A. J. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients. Acta Neuropathol. 1989;79(2):160–167. doi: 10.1007/BF00294374. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES